107 related articles for article (PubMed ID: 24959968)
41. Synthetic Site-Selectively Mono-6-O-Sulfated Heparan Sulfate Dodecasaccharide Shows Anti-Angiogenic Properties In Vitro and Sensitizes Tumors to Cisplatin In Vivo.
Avizienyte E; Cole CL; Rushton G; Miller GJ; Bugatti A; Presta M; Gardiner JM; Jayson GC
PLoS One; 2016; 11(8):e0159739. PubMed ID: 27490176
[TBL] [Abstract][Full Text] [Related]
42. Single-Step Per-O-Sulfonation of Sugar Oligomers with Concomitant 1,6-Anhydro Bridge Formation for Binding Fibroblast Growth Factors.
Yeh CJ; Ku CC; Lin WC; Fan CY; Zulueta MML; Manabe Y; Fukase K; Li YK; Hung SC
Chembiochem; 2019 Jan; 20(2):237-240. PubMed ID: 30239102
[TBL] [Abstract][Full Text] [Related]
43. Differentiation-associated modulation of heparan sulfate structure and function in CaCo-2 colon carcinoma cells.
Salmivirta M; Safaiyan F; Prydz K; Andresen MS; Aryan M; Kolset SO
Glycobiology; 1998 Oct; 8(10):1029-36. PubMed ID: 9719684
[TBL] [Abstract][Full Text] [Related]
44. Glypican-1 drives unconventional secretion of fibroblast growth factor 2.
Sparn C; Dimou E; Meyer A; Saleppico R; Wegehingel S; Gerstner M; Klaus S; Ewers H; Nickel W
Elife; 2022 Mar; 11():. PubMed ID: 35348113
[TBL] [Abstract][Full Text] [Related]
45. Embryonic Stem Cell Engineering with a Glycomimetic FGF2/BMP4 Co-Receptor Drives Mesodermal Differentiation in a Three-Dimensional Culture.
Naticchia MR; Laubach LK; Tota EM; Lucas TM; Huang ML; Godula K
ACS Chem Biol; 2018 Oct; 13(10):2880-2887. PubMed ID: 30157624
[TBL] [Abstract][Full Text] [Related]
46. A synthetic heparan sulfate pentasaccharide, exclusively containing L-iduronic acid, displays higher affinity for FGF-2 than its D-glucuronic acid-containing isomers.
Kovensky J; Duchaussoy P; Bono F; Salmivirta M; Sizun P; Herbert JM; Petitou M; Sinaÿ P
Bioorg Med Chem; 1999 Aug; 7(8):1567-80. PubMed ID: 10482449
[TBL] [Abstract][Full Text] [Related]
47. Transport of fibroblast growth factor 2 in the pericellular matrix is controlled by the spatial distribution of its binding sites in heparan sulfate.
Duchesne L; Octeau V; Bearon RN; Beckett A; Prior IA; Lounis B; Fernig DG
PLoS Biol; 2012 Jul; 10(7):e1001361. PubMed ID: 22815649
[TBL] [Abstract][Full Text] [Related]
48. The molecular phenotype of heparan sulfate in the Hs2st-/- mutant mouse.
Merry CL; Bullock SL; Swan DC; Backen AC; Lyon M; Beddington RS; Wilson VA; Gallagher JT
J Biol Chem; 2001 Sep; 276(38):35429-34. PubMed ID: 11457822
[TBL] [Abstract][Full Text] [Related]
49. The Startling Properties of Fibroblast Growth Factor 2: How to Exit Mammalian Cells without a Signal Peptide at Hand.
La Venuta G; Zeitler M; Steringer JP; Müller HM; Nickel W
J Biol Chem; 2015 Nov; 290(45):27015-27020. PubMed ID: 26416892
[TBL] [Abstract][Full Text] [Related]
50. Structural analysis of synthetic heparan sulfate oligosaccharides with fibroblast growth factors and heparin-binding hemagglutinin.
Zulueta MML; Chyan CL; Hung SC
Curr Opin Struct Biol; 2018 Jun; 50():126-133. PubMed ID: 29554552
[TBL] [Abstract][Full Text] [Related]
51. Lack of L-iduronic acid in heparan sulfate affects interaction with growth factors and cell signaling.
Jia J; Maccarana M; Zhang X; Bespalov M; Lindahl U; Li JP
J Biol Chem; 2009 Jun; 284(23):15942-50. PubMed ID: 19336402
[TBL] [Abstract][Full Text] [Related]
52. Construction of heparan sulfate microarray for investigating the binding of specific saccharide sequences to proteins.
Horton M; Su G; Yi L; Wang Z; Xu Y; Pagadala V; Zhang F; Zaharoff DA; Pearce K; Linhardt RJ; Liu J
Glycobiology; 2021 Apr; 31(3):188-199. PubMed ID: 32681173
[TBL] [Abstract][Full Text] [Related]
53. Structural insights into heparanase activity using a fluorogenic heparan sulfate disaccharide.
Wu L; Wimmer N; Davies GJ; Ferro V
Chem Commun (Camb); 2020 Nov; 56(89):13780-13783. PubMed ID: 33073275
[TBL] [Abstract][Full Text] [Related]
54. Visualizing antithrombin-binding 3-
Kalita M; Chua JS; Boothello RS; Joice A; Antelope O; Roy A; Anandh Babu PV; Saijoh Y; Desai UR; Kuberan B
Chem Commun (Camb); 2020 Nov; 56(92):14423-14426. PubMed ID: 33146178
[TBL] [Abstract][Full Text] [Related]
55. Heparan sulphate in breast cancer cells.
Rahmoune H; Turnbull JE; Gallagher JT; Rudland PS; Fernig DG
Biochem Soc Trans; 1996 Aug; 24(3):355S. PubMed ID: 8878899
[No Abstract] [Full Text] [Related]
56. Characterization and engineering of S100A12-heparan sulfate interactions.
Zhang X; Ong C; Su G; Liu J; Xu D
Glycobiology; 2020 Jul; 30(7):463-473. PubMed ID: 31942981
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and mass spectrometric analysis of disaccharides from methanolysis of heparan sulfate.
He QQ; Trim PJ; Snel MF; Hopwood JJ; Ferro V
Org Biomol Chem; 2018 Nov; 16(45):8791-8803. PubMed ID: 30403218
[TBL] [Abstract][Full Text] [Related]
58. Single-Molecule Fluorescence Detection of a Synthetic Heparan Sulfate Disaccharide.
Dalton CE; Quinn SD; Rafferty A; Morten MJ; Gardiner JM; Magennis SW
Chemphyschem; 2016 Nov; 17(21):3442-3446. PubMed ID: 27538128
[TBL] [Abstract][Full Text] [Related]
59. Heparan sulphate and protein recognition. Binding specificities and activation mechanisms.
Gallagher JT
Adv Exp Med Biol; 1995; 376():125-34. PubMed ID: 8597238
[No Abstract] [Full Text] [Related]
60. Circulating heparan sulfate fragments mediate septic cognitive dysfunction.
Hippensteel JA; Anderson BJ; Orfila JE; McMurtry SA; Dietz RM; Su G; Ford JA; Oshima K; Yang Y; Zhang F; Han X; Yu Y; Liu J; Linhardt RJ; Meyer NJ; Herson PS; Schmidt EP
J Clin Invest; 2019 Apr; 129(4):1779-1784. PubMed ID: 30720464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
